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Summary
 
Histamine is considered one of the important mediators of immediate hypersensitivity and in-
flammation, and acts via G protein–coupled receptors. Here, we report that histamine may af-
fect antigen receptor–mediated immune responses of T and B cells via a signal(s) from hista-
mine H1 receptors (H1Rs). Histamine exhibited enhancing effects on the in vitro proliferative
responses of anti-CD3
 
e
 
– or anti-IgM–stimulated spleen T and B cells, respectively, at the cul-
ture condition that the fetal calf serum was dialyzed before culture and c-kit–positive cells were
depleted from the spleen cells. In studies of histamine H1R knockout mice, H1R-deficient T
cells had low proliferative responses to anti-CD3
 
e
 
 cross-linking or antigen stimulation in vitro.
B cells from H1R-deficient mice were also affected, demonstrating low proliferative responses
to B cell receptor cross-linking. Antibody production against trinitrophenyl-Ficoll was reduced
in H1R-deficient mice. Other aspects of T and B cell function were normal in the H1R
knockout mice. H1R-deficient T and B cells showed normal responses upon stimulation with
interleukin (IL)-2, IL-4, CD40 ligand, CD40 ligand plus IL-4, and lipopolysaccharide. Collec-
tively, these results imply that the signal generated by histamine through H1R augments anti-
gen receptor–mediated immune responses, suggesting cross-talk between G protein–coupled
receptors and antigen receptor–mediated signaling.
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G
 
uanine-nucleotide binding (G)
 
1
 
 protein–coupled re-
ceptors (GPCRs) link to downstream signaling path-
ways through activation of heterotrimeric G proteins,
which are composed of three subunits, termed 
 
a
 
, 
 
b
 
, and 
 
g
 
(1, 2) in an inactive state. Upon ligand/agonist binding,
GPCRs stimulate the 
 
a
 
 subunit of heterotrimeric G pro-
tein to release GDP and to bind GTP in its place. In the
GTP-bound form, a G
 
a
 
 dissociates from a G
 
bg
 
 dimer,
each of which independently binds and activates target ef-
fectors. The 
 
a
 
 subunits that bind and hydrolyze GTP are
classified into four subfamilies based on sequence homol-
ogy and shared effector molecules: G
 
a
 
s, G
 
a
 
i, G
 
a
 
q, and
G
 
a
 
12 (1–3). Intracellular signaling pathways regulated by
GPCRs include the cAMP/protein kinase A pathway, the
phosphatidyl inositol/calcium/protein kinase pathway me-
diated by phospholipase C
 
b
 
 (PLC
 
b
 
) and the mitogen-acti-
vated protein kinase (MAPK) pathway (4). Recent studies
have provided strong evidence that in some cell types acti-
vation of MAPK pathway by GPCR is tyrosine kinase de-
pendent (5–8). The genetic and biochemical analysis clearly
provides evidence that protein tyrosine kinase cascade bridges
G protein and MAPK pathways in mammalian cells (9).
The G
 
a
 
 subunits that regulate activity of PLC
 
b
 
 belong to
the Gq class (G
 
a
 
q, G
 
a
 
11, G
 
a
 
14, G
 
a
 
15/16; references 10,
11). Tyrosine phosphorylation of the G
 
a
 
q/11 subunit by
protein tyrosine kinases (PTKs) contributes to GPCR-
mediated activation of Gq/11 (12, 13) followed by hydrol-
ysis of phosphatidylinositol phosphates and production of
inositol-1,4,5-triphosphate (IP3) and diacylglycerol. Tyro-
sine-phosphorylated G
 
a
 
q/11 has been shown to be more
active in stimulating PLC
 
b
 
 in vitro (12).
Protein tyrosine phosphorylation is an important event
in the initiation of cellular responses triggered by antigen
receptors on both B and T cells (14–16). One of the initial
intracellular signaling events after cross-linking of the B cell
antigen-receptors (BCR) with antigens is the activation of
non-receptor type PTKs, such as Src family kinases (Lyn,
Blk, Fyn), Syk kinase, and Bruton’s tyrosine kinase (Btk)
(15). Activation of the PTKs of the Src family such as Lck
and Fyn, followed by the activation of ZAP-70 kinase, has
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; Btk, Bruton’s
tyrosine kinase; GPCR, G protein–coupled receptor; G protein, guanine-
nucleotide binding protein; HRP, horseradish peroxidase; MAPK, mito-
gen-activated protein kinase; PLC, phospholipase C; PTK, protein
tyrosine kinases; TMB, tetramethylbenzidine. 
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been implicated in an initial step of TCR signal transduc-
tion (14). These protein tyrosine kinases rapidly phos-
phorylate a number of intracellular substrates and activate
signaling cascades that include activation of phospholipase
C
 
g
 
-1 and 2 (PLC
 
g
 
1, 
 
g
 
2), phosphatidylinositol 3 kinase
(PI3 kinase), and the Ras–MAPK pathway, which trans-
mits further biochemical events that eventually regulate cell
cycle and gene expression.
It has been shown that GTP exchange within G
 
a
 
q/11
and physical association of G
 
a
 
q/11 with CD3
 
e
 
 are induced
upon cross-linking of the TCR by anti-CD3
 
e
 
 antibody
(17). Moreover, it was demonstrated that upon TCR en-
gagement G
 
a
 
q/11 is activated by a tyrosine kinase-depen-
dent process that mediates both tyrosine phosphorylation of
immunoreceptor tyrosine activation motif (ITAM) on
CD3 molecules and IP3 generation through activation of
PLC
 
b
 
. Interestingly, tyrosine phosphorylation of TCR-
 
z
 
and CD3
 
e
 
 chains as well as ZAP-70 were diminished upon
anti-CD3 antibody triggering in cells transfected with a
function-loss mutant of G
 
a
 
11 (17). These data suggest the
involvement of the G
 
a
 
q/11 family in TCR signaling and a
reciprocal regulation between tyrosine kinases and G pro-
teins during the initial stages of TCR-mediated signaling
(3). Activation of tyrosine kinases Pyk2 and Src may link
Gi- and Gq-coupled receptors to the MAPK pathway in
certain cell types (18, 19). The cross-linking of antigen re-
ceptors also induced Pyk2 activation in T cells (20). Thus,
Pyk2 may potentially serve as a convergence point for
TCR and GPCR signaling. Moreover, it was shown that
Gq-mediated signaling could trigger the translocation of
the transcription factor, nuclear factor (NF)-AT, to the nu-
cleus upon TCR-mediated T cell activation (21). Among
chemokine receptors that are associated with GPCRs,
RANTES (regulated on activation, normal T cell expressed
and secreted) could activate ZAP-70, which plays a crucial
role in TCR-mediated signaling (22).
In B cells, G
 
a
 
q activates Btk (23), and G
 
bg
 
 subunits
have been also reported to bind and activate Btk (24, 25).
Thus, engagement of either the BCR or a Gq-linked
GPCR could activate Btk in B cells (3). Based on selective
gene targeting in an avian B lymphoma cell line, DT40,
MAPK activation through Gi-coupled receptors requires
Btk and Syk, whereas Gq-coupled receptors require Csk,
Lyn, and Syk (9).
Histamine is known to be a neurotransmitter (26), an in-
flammatory mediator, a factor in anaphylaxis, and a regula-
tor of cardiac and gastrointestinal function. The pharmaco-
logical effects of histamine are mediated through three
types of membrane receptors, H1, H2, and H3 (27). The
H1R possesses all the structural features of GPCRs, includ-
ing seven putative transmembrane domains, NH
 
2
 
-terminal
glycosylation sites, and phosphorylation sites for protein ki-
nase A and protein kinase C (28). It has been detected in
mammalian brain (29), smooth muscle from airway (31,
32), gastrointestinal tract (33), genitourinary system (34),
vascular smooth muscle (35), and lymphocytes (36, 37).
Upon H1R stimulation, various intracellular responses,
such as production of inositol phosphates, increase in Ca
 
2
 
1
 
influx, cyclic AMP and cyclic GMP accumulation, and
arachidonic acid release (27, 38), are induced through cou-
pling of the H1Rs to the heterotrimeric G proteins (27, 39,
40). The primary mechanism by which the H1R produces
these functional responses in cells is the activation of PLC
through a pertussis toxin–insensitive G protein that is re-
lated to the G
 
a
 
q/11 family of G proteins (26, 27). It has
also been reported that the histamine-induced production
of inositol phosphates was inhibited by an antibody against
G
 
a
 
q-like proteins (41). These data suggest the involvement
of a member of G
 
a
 
q family of the G proteins in H1R-
mediated signal transduction.
In this study, we have used H1R knockout mice (42) to
demonstrate that histamine affects antigen receptor–medi-
ated immune responses by T and B cells via signal(s) from
histamine H1Rs, and we suggest the possibility of a recip-
rocal regulation between GPCRs and antigen receptor–
mediated signaling.
 
Materials and Methods
 
Generation of H1R
 
2
 
/
 
2
 
 Mice.
 
The histamine H1R knockout
mice were established in our lab and have been described previ-
ously (42). The H1R
 
2
 
/
 
2
 
 129 
 
3
 
 C57BL/6 mice were back-
crossed to C57BL/6 in our animal facility under pathogen-free
conditions with proper aeration, light, and temperature.
 
Genotype Determination by Southern Hybridization.
 
Genomic
DNA (10 
 
m
 
g) was digested with EcoRI and subjected to agarose
gel electrophoresis. DNA was transferred onto nucleic acid trans-
fer membranes (Hybond TM
 
2
 
 N
 
1
 
; Amersham) by alkali blot-
ting. Filters were hybridized with radiolabeled DNA probes, and
then washed in 0.1
 
3
 
 SSC, 0.1% (wt/vol) SDS at 60
 
8
 
C for 30
min before autoradiography.
 
Cell Culture and Proliferation Assay.
 
Splenic B cells were pre-
pared by the treatment of spleen cells with anti–mouse Thy 1.2
mAb for 30 min on ice and then with complement for 30 min at
37
 
8
 
C for depletion of T cells. To remove the adherent cells, cells
were incubated at 37
 
8
 
C for 1 h and nonadherent cells were col-
lected by Ficoll-Hypaque density centrifugation. Red blood cells
were lysed with NH
 
4
 
Cl lysis buffer. After washing, cell purity
was measured by FACS
 
®
 
 analysis. Splenic T cells were prepared
by passing spleen cells through a nylon wool column, and eryth-
rocytes were lysed with NH
 
4
 
Cl lysis buffer. Cells were suspended
in RPMI 1640 medium containing 10% heat-inactivated FCS
(GIBCO BRL), 20 
 
m
 
g/ml gentamycin, 0.05 mM 2-ME, and 2 mM
 
l
 
-glutamine, and cultured at a final concentration of 5 
 
3
 
 10
 
5
 
cells/ml in 200-
 
m
 
l/well aliquots in flat-bottomed 96-well tissue
culture plates (Becton Dickinson) at 37
 
8
 
C with 5% CO
 
2
 
 for 72 h.
FCS was dialyzed twice against RPMI 1640 media at 4
 
8
 
C over-
night. Various stimuli were added to the cells: LPS (Difco), goat
F(ab)
 
2
 
 anti–mouse IgM (Southern Biotechnology Associates),
rIL-4 (R & D Systems), soluble CD40 ligand (CD40L) (CD8 fu-
sion protein contained in the culture supernatant [30% vol/vol]
of a transfected myeloma cell line, provided by Dr. P. Lane, Basel
Institute of Immunology, Basel, Switzerland), rIL-2 (R & D Sys-
tems), and goat anti–mouse CD3
 
e
 
 (PharMingen). The cultures
were pulsed for the last 18 h with 0.5 
 
m
 
Ci/ml [
 
3
 
H]thymidine
(Amersham). After cell harvesting onto fiber glass filters (Printed
Filter Mat A; Wallac OY, Turku, Finland), cell proliferation was
determined by measuring [
 
3
 
H]thymidine incorporation with a
beta plate counter (Wallac OY). FCS was dialyzed before use 
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against RPMI 1640 medium overnight at 4
 
8
 
C by changing me-
dium twice.
 
Depletion of c-kit–positive Cells.
 
Total spleen cells or purified B
cells were suspended in serum-free RPMI 1640 media after red
blood cell lysis. 10
 
7 
 
cells/ml were incubated for 45 min on ice
with 100 
 
m
 
l of 50 
 
m
 
g/ml rat IgG anti–c-kit mAb (clone ACK; a
gift from Dr. S. Nishikawa, Kyoto University, Kyoto, Japan). Af-
ter centrifugation at 4
 
8
 
C, cells were resuspended in 1 ml of se-
rum-free media. Using a 21-gauge needle, 250 
 
m
 
l of 10
 
8
 
 anti–rat
IgG-coated beads (Dynabeads; Dynal AS) were added to the sus-
pended cells and incubated for 5 min on ice. The incubated cells
were centrifuged for 10 min at 4
 
8
 
C. After gentle pipetting, the
Eppendorf tube was placed in front of a magnetic bar. The c-kit–
positive cells were attached to the magnet. The nonattached cells
were collected, washed, and finally resuspended in RPMI 1640
culture media containing 10% dialyzed FCS.
 
Immunization with OVA and Antigen-specific T cell Proliferation.
 
The wild-type (
 
1
 
/
 
1
 
) and H1R knockout (
 
2
 
/
 
2
 
) mice (8–10
wk of age) were immunized intraperitoneally with 100 
 
m
 
g of
ovalbumin (Sigma Chemical Co.) emulsified in 1 mg aluminum
hydroxide (alum) (Sigma Chemical Co.) in 200 
 
m
 
l of PBS. Mice
were immunized twice with a 2-wk interval. Spleen cells were
isolated 2 wk after the last injection and cultured for 3 d in the
presence of different concentrations of OVA. Antigen-specific
proliferative responses of spleen cells were measured by [
 
3
 
H]thy-
midine incorporation followed by a 12-h pulse at the end of 3 d
of culture.
 
Immunization with TNP-Ficoll and Measurement of Anti-TNP
Antibody.
 
Wild-type and H1R knockout mice (8–10 wk of age)
were immunized intraperitoneally once with 25 
 
m
 
g of TNP-
Ficoll (a gift from Dr. S. Ono, Osaka University, Osaka, Japan) in
200 
 
m
 
l PBS. After 10 d, the serum was collected and anti-TNP
IgM antibody titer was measured by ELISA. For ELISA, flat-bot-
tomed 96-well probind assay plates (Becton Dickinson) were
coated with TNP-BSA at 4
 
8
 
C overnight. After blocking the
nonspecific binding sites, serial dilutions of the sera were added
(100 
 
m
 
l/well, in triplicate) and plates were incubated for 1 h at
room temperature. After washing three times, horseradish perox-
idase–conjugated anti–mouse IgM antibodies (Biosource Interna-
tional) were added and incubated at room temperature for 1 h.
Finally, tetramethylbenzidine (TMB) peroxidase substrates
(Kirkegaard and Perry Labs.) were added to each well and incu-
bated for 5 min. The reaction was stopped by adding 1 M
H
 
3
 
PO
 
4
 
. Absorbance at 450 nm was determined using a model
550 automatic microplate reader (Bio-Rad).
 
Titration of Isotype-specific Serum Igs and Anti-OVA Antibodies.
 
The 96-well flat-bottomed probind assay plates (Becton Dickinson)
were coated with 10 
 
m
 
g/ml of isotype-specific goat anti–mouse an-
tibodies overnight at 4
 
8
 
C. After washing uncoated antibodies, plates
were blocked with 5% nonfat milk at room temperature for 1 h.
The serially diluted sera from unimmunized mice were added to the
wells and incubated at room temperature for 1 h. The HRP-labeled
isotype-specific antibodies (Southern Biotechnology Associates)
were applied to the plate and incubated for 2 h at room tempera-
ture. The TMB peroxidase substrate was added to each well for
5 min. Finally, the reaction was stopped by adding the stop solution
(1 M H
 
3
 
PO
 
4
 
) and absorbance at 450 nm was measured using a
model 550 automatic microplate reader (Bio-Rad Labs.).
For determination of isotype-specific anti-OVA antibodies in
sera that were collected 2 wk after second immunization with
OVA (100 
 
m
 
g/mouse) attached to alum, the assay plates were
coated first with OVA (10 
 
m
 
g/ml) in 200 
 
m
 
l/well of PBS and in-
cubated overnight. After washing plates with PBS, they were
 
blocked with 5% nonfat milk at room temperature for 1 h. Seri-
ally diluted sera from OVA-immunized mice were added to the
wells of plates and incubated at room temperature for 1 h. HRP-
labeled isotype-specific antibodies were used for determination of
the antibody titer of each Ig subclass.
 
Flow Cytometric Analysis.
 
Single cell suspensions from freshly
isolated red blood cell lysed thymocytes, splenocytes, and bone
marrow were prepared, and 2 
 
3
 
 10
 
5
 
 cells/ml were stained with
mAbs for 30 min on ice in PBS containing 2% FCS and 0.5%
NaN
 
3
 
. Cells were washed with PBS and analyzed by FACScan
 
®
 
with Cellquest software (Becton Dickinson). mAbs used for the
staining were labeled with FITC or PE. mAbs to B220, CD5,
CD4, and CD8 were obtained from PharMingen, and anti-IgM
and -IgD were from Southern Biotechnology Associates, Inc.
Streptavidin red 670 (PharMingen) was used as a third color for
FACS
 
® analysis.
Measurement of Cytokine Production. Spleen cells (4 3 106/
well) were cultured in a 24-well culture plate (Costar Co.) with
OVA at various concentrations (0, 5, 10, 20, 30, 40, or 50 mg/
ml) or in anti-CD3e antibody–coated (10 mg/ml) plates. The
amounts of secreted cytokines were determined by ELISA. In
brief, supernatants were collected after 72 h of culture. The
amounts of IL-4 and IL-2 in the supernatants were determined
by a quantitative sandwich ELISA method using the Biotrack and
Amersham mouse IL-4 and IL-2 kit (Amersham International).
Following the manufacturer’s protocol, the cultured supernatants
were added to plates that had been precoated with mouse IL-4 or
IL-2 mAb. The HRP-conjugated anti–mouse IL-4 or IL-2 mAb
was added to the plate and incubated at 378C for 1 h. Bound cy-
tokines were detected by the addition of TMB substrate. The
stop solution (0.18 M sulphuric acid) was added to cease the reac-
tion. The IFN-g in the culture supernatants was determined by
using the Titerzyme Mouse IFN-g EIA Kit (Perseptive Diagnos-
tics, Inc.). According to the described protocol, the culture su-
pernatant was applied to the mouse IFN-g antibody precoated
well and incubated at room temperature for 2 h in horizontal or-
bital rotor. After a thorough washing of the plates, the wells were
covered with 50 ml of mouse IFN-g antibody and incubated at
room temperature for 2 h. After washing, HRP-conjugated goat
anti–rabbit IgG was applied to the wells and incubated at room
temperature for 30 min. TMB substrate solution was added after
proper washing and incubated at room temperature for 15 min.
Finally, 1 N HCl was used to stop the reaction. The absorbance
was determined at 450 nm using a Model 550 automatic micro-
plate reader (Bio-Rad Labs.). Cytokine levels were calculated
from a log–log plot of absorbence versus known concentration of
recombinant cytokines. Results were expressed in picograms per
milliliter.
Immunoprecipitation and Western Blot Analysis. After depletion
of c-kit–positive cells from H1R1/1 spleen cell suspension, 107
cells of wild-type or H1R2/2 mice in 1 ml of RPMI 1640 media
with 10% dialyzed FCS were stimulated with goat anti–mouse
CD3e (10 mg/ml) in the presence or absence of 1025 M hista-
mine at 378C for 0, 1, 5, and 10 min. The anti-CD3e-stimulated
cells were centrifuged and the pellets were lysed in 1 ml cold lysis
buffer (10 mM Tris, pH 7.4, 1.0% Triton X-100, 0.5% NP-40,
150 mM NaCl, 20 mM sodium fluoride, 0.2 mM sodium ortho-
vanadate, 1.0 mM EDTA, and 1.0 mM EGTA) containing pro-
tease inhibitors (0.2 mM PMSF, 10 mg/ml aprotinine, 10 mg/ml
leupeptin) for 30 min on ice with periodic vortexing. After lysis,
the samples were centrifuged and the supernatants were frozen at
2708C before assay. Protein concentration of the lysates was as-
sayed by using the BCA Reagents Kit (Pierce Chemical Co.) ac-676 Effect of Histamine on Immune Responses
cording to the manufacturer’s instructions. ZAP-70 kinase was
immunoprecipitated from lysates (0.4 mg total protein) with 2 mg
of soluble anti–ZAP-70 antibody for 1 h at 48C with end-over-
end rotation. The immune complexes were captured with 10 ml
of 50% suspended protein G–agarose (Sigma Chemical Co.) for
30 min at 48C with constant rotation. The immunoprecipitates
were washed three times with immunoprecipitation (IP) buffer
(10 mM Tris, pH 7.4, 1.0% Triton X-100, 0.5% NP-40, 150 mM
NaCl, 0.2 mM sodium ortho-vanadate, 1.0 mM EDTA, 1.0 mM
EGTA, 0.2 mM PMSF), followed by a centrifugation at 15,000
rpm for 4 min at 48C. The collected immunoprecipitates were
then dissociated in boiled SDS-PAGE sample buffer containing
2-ME and fractionated on 10% SDS-polyacrylamide gels. The
proteins on the gels were transferred onto nitrocellulose mem-
brane filter (PROTRAN; Schleicher & Schnell, Inc.) and probed
with HRP-labeled antiphosphotyrosine mAb, PY-20 (Transduc-
tion Labs.). The blots were developed by the chemiluminescence
(ECL) reagents (Amersham Corp.) and Biomax TM MR film
(Eastman Kodak Co.).
Results
Histamine-enhanced Antigen Receptor–mediated T and B Cell
Proliferative Responses. Mouse spleen T and B cells were
initially cultured in medium containing 10% standard FCS
and stimulated with anti-CD3e (10 mg/ml) or anti-IgM
(10 mg/ml) antibodies in the presence of varying concen-
trations of histamine. Histamine had no effect on anti-
CD3e or anti-IgM–stimulated T or B cell proliferation. To
eliminate any effect of preexisting histamine or its deriva-
tives in FCS, the serum was dialyzed against RPMI 1640
culture medium before use, and c-kit–positive spleen cells,
which are presumably mast cells, were removed. Splenic T
(Fig. 1 A) or B cells (Fig. 1 B) were stimulated with anti-
CD3e antibody or anti-IgM antibody, respectively, in the
presence of various concentration of histamine. Histamine
enhanced the proliferative responses of T and B cells at an
optimum concentration of 10 mM for both cell types by
about twofold. However, histamine did not show any ef-
fect on the proliferative responses unless the FCS was dia-
lyzed before culture and c-kit–positive cells were depleted
from the spleen cells (data not shown).
In contrast, the histamine-induced augmentation of anti-
gen receptor–mediated proliferative responses of both T
and B cells was not observed in spleen cells obtained from
histamine H1R–deficient mice (Fig. 2) when cultured un-
der the same conditions. These results indicate that hista-
mine H1R–mediated signal(s) are responsible for the en-
hancing effect observed by the addition of histamine. It is
noteworthy that the level of thymidine incorporation of
H1R2/2 splenic T and B cells upon antigen receptor cross-
linking was very low when compared with that of spleen
cells from wild-type mice in the absence of histamine, as
shown in Fig. 1.
Analysis of the Low Proliferative Responses Induced by Anti-
gen Receptor Cross-linking in Histamine H1R2/2 Mice.
Splenic T and B cells prepared from histamine H1R2/2
mice and normal littermates (1/1) were cultured in the
presence of varying concentrations of anti-CD3e (Fig. 3 A)
and anti-IgM (Fig. 3 B), respectively. After 72 h of culture,
proliferative responses were assayed by [3H]thymidine in-
corporation. The proliferative responses of T cells in
H1R2/2 mice to anti-CD3e were five- to eightfold lower
than those of normal littermate controls. Similarly, re-
sponses to anti-IgM stimulation of B cells from H1R2/2
mice were decreased three- to fourfold compared to wild-
type mice.
Both H1R2/2 and wild-type mice were immunized
twice with OVA to examine antigen-specific responses.
Splenic T cells prepared from immunized mice were cul-
tured in the presence of varying concentrations of OVA
Figure 1. Enhancing effect of histamine on proliferative responses of
c-kit–positive cell-depleted spleen T and B cells cultured in media con-
taining dialyzed FCS. c-kit–positive cells were removed from total spleen
cells and splenic B cells of wild-type C57/Bl mice were purified as
described in Materials and Methods. c-kit–positive cell-depleted spleen T
and B cells (5 3 105 cells/ml) were cultured for 72 h in RPMI 1640 me-
dium containing dialyzed FCS and stimulated with (A) anti-CD3e (10
mg/ml) or (B) anti–mouse IgM (10 mg/ml) in the presence of different
concentrations of histamine. The cells were pulsed for 12 h with [3H]thy-
midine before the end of culture. Shown is one representative experiment
out of three.
Figure 2. Low proliferative responses of T and B cells of H1R2/2 mice
against anti-CD3e and anti–mouse IgM stimulation. Total spleen cells
and purified splenic B cells from H1R2/2 mice were cultured in RPMI
1640 medium containing dialyzed FCS after depletion of c-kit–positive
cells. Total spleen cells and purified B cells were stimulated with anti-
CD3e (A) and anti–mouse IgM (B), respectively, in the presence of dif-
ferent concentrations of histamine. The DNA synthesis was measured by
pulsing with [3H]thymidine for 12 h before the end of culture. Shown is
one representative experiment out of three.677 Banu and Watanabe
(Fig. 3 C). Proliferative responses to OVA antigen of
H1R2/2 T cells were four- to sixfold reduced as compared
with the responses of the wild-type littermates. These data
indicated that TCR- and BCR-mediated proliferative re-
sponses of T or B cells from mice lacking the histamine
H1R were impaired, suggesting that a signal(s) from the
histamine H1R upon ligand binding may play an indis-
pensable role in signaling pathways originating from TCR
and BCR complexes.
Decreased Antibody Production against a T Cell–independent
Antigen in H1R2/2 Mice. Impaired responses of splenic B
cells to anti-IgM stimulation in H1R2/2 mice suggested a
significant role for the signal derived from the histamine
H1R complex. H1R2/2 and their wild-type littermates
were challenged with the T cell–independent antigen,
TNP-Ficoll (Fig. 4). After 10 d, sera were collected and
antibodies to the TNP hapten were measured. Anti-TNP
IgM antibody titer was low (about ninefold) in H1R2/2
mice, indicating a crucial augmenting role for the interac-
tion between ligands and H1Rs in responses triggered from
BCRs.
Normal Proliferative Responses to Cytokines or Mitogens in
H1R2/2 Mice. Splenic T cells of H1R2/2 and wild-type
mice were cultured in the presence of various concentra-
tion of IL-2. The thymidine incorporation was measured
72 h after culture and the level of the responses was not sig-
nificantly changed (Fig. 5 A). Splenic B cells from H1R2/2
and wild-type mice were cultured with IL-4 alone (Fig. 5
B) or in combination with CD40L (Fig. 5 C). Again, no
significant difference was observed in the proliferative po-
Figure 3. Low proliferative re-
sponses of splenic T and B cells of
histamine H1R2/2 mice upon cross-
linking of antigen receptors. Total
spleen cells and purified B cells from
unimmunized wild-type mice (1/1,
white bars) and H1R2/2 mice (2/2,
black bars) were cultured with vari-
ous concentrations of (A) anti-CD3e
antibody or (B) anti-IgM antibody
for 72 h. (C) The H1R2/2 and
wild-type mice were immunized in-
traperitoneally with OVA (100 mg/
mouse) emulsified in alum as de-
scribed in Materials and Methods.
Mice were immunized twice in a 2-wk interval. 2 wk after the last immu-
nization, the mice were killed and spleen cells from both wild-type and
H1R2/2 mice were cultured in presence of OVA (5–50 mg/ml) for 3 d.
Cell proliferation was measured with [3H]thymidine incorporation by
pulsing for 12 h at the end of culture. Mean CPM and SD were calcu-
lated from triplicate cultures. Shown is one representative experiment out
of four.
Figure 4. Reduced antibody
response to T cell–independent
antigen, TNP-Ficoll, in H1R2/2
mice. Both the H1R2/2 (2/2)
and wild-type mice (1/1) re-
ceived one intraperitoneal im-
munization of TNP-Ficoll (25
mg/mouse) in 200 ml of 13
PBS. Sera were collected from
three mice of each group on day
10 after immunization. Anti-
TNP IgM antibody titer in se-
rum was measured by ELISA, as
described in Materials and Meth-
ods. The antibody titer was de-
termined by measuring the opti-
cal density in 450 nm. Data are
plotted as mean 6 SD.
Figure 5. Normal proliferative responses to IL-2, IL-4, CD40L,
CD40L plus IL-4, and LPS in H1R2/2 mice. Total spleen cells from
H1R2/2 (black bars) and their wild-type littermates (white bars) were
cultured with medium alone or various concentrations of IL-2 (A) or IL-4
(B). Splenic B cells were cultured with CD40L–CD8 chimeric protein
(CD40L) alone or in combination with IL-4 (C) or LPS (D). Cells were
cultured for 3 d and pulse-labeled with [3H]thymidine for the final 18 h.
All cultures were performed in triplicate.678 Effect of Histamine on Immune Responses
tential of splenic B cells from wild-type or H1R2/2 mice,
demonstrating that signals from histamine H1Rs do not
modulate signaling in CD40-mediated proliferative re-
sponse. Response of B cells to the mitogen, LPS (Fig. 5 D),
and of T cells to the T cell mitogen, PHA, were also not
significantly affected by H1R deficiency (data not shown).
These data suggest that signals from H1Rs may not affect
the intracellular signals induced by mitogen, cytokines, or
costimulatory molecules, but exhibit augmenting effects on
antigen receptor–mediated responses.
Secondary Antibody Response against the T Cell–dependent
Antigen, OVA, in H1R2/2 Mice. Mice were immunized
twice with OVA (100 mg per mouse) emulsified with 1 mg
Alum in 200 ml of PBS, and sera were collected 14 d after
the second immunization. Antibody titer of each Ig class
was measured by ELISA with isotype-specific antibodies.
In unimmunized mice, serum level of each Ig subclass in
H1R2/2 mice was comparable to that of normal mice ex-
cept for IgG3 class, which showed a slightly lower level in
mutant mice as shown in Fig. 6 A. After immunization, to-
tal IgG of antibodies to OVA in H1R2/2 mice was compa-
rable to that of normal littermates. But, as shown in Fig. 6
B, IgG3 and IgM subclasses of anti-OVA antibodies in
H1R2/2 mice were significantly lower than those of con-
trol mice (P , 0.01). IgG2a subclass of antibodies was also
somewhat low in mutant mice, but was not statistically sig-
nificant. These data suggested that antibody production of
the IgM and IgG3 subclasses may be impaired in the mice
lacking H1Rs.
Lymphocyte Profiles in Spleen, Bone Marrow, Thymus, and
Peritoneal Cavity in H1R2/2 Mice. Single cell suspension
of thymocytes, splenocytes, peritoneal exudated cells, and
bone marrow cells were stained with various FITC-conju-
gated mAbs. No difference in total cell numbers was
observed in each organ. FACS® analysis showed no signifi-
cant difference in numbers of total or T and B cell subpop-
ulation distribution in the profiles of thymus, bone mar-
row, and spleen in the histamine H1R2/2 mice (data not
shown). Level of expression of IgM on B cells or CD3 on
T cells of H1R2/2 mouse did not change and was compa-
rable to that of wild-type littermates, although the numbers
of CD51, B2201 cells in peritoneal cavity in histamine
H1R2/2 mice were slightly decreased to about a half of
those of normal littermates (21.0 6 8.6% versus 39.5 6
9.1% of total peritoneal exudated cells). These data indi-
cated that the absence of the histamine H1Rs does not af-
fect the development and differentiation of mature T and B
lymphoid cells, but may affect the development of B1 cells
in the peritoneal cavity.
Reduced Tyrosine Phosphorylation of ZAP-70 Kinase in
H1R2/2 Mouse T Cells. The low proliferative response of
T cell of H1R2/2 mice after triggering with anti-CD3e or
antigen (OVA) (Figs. 1 and 3) may suggest a low protein ty-
rosine phosphorylation in intracellular signaling events.
ZAP-70 kinase is known to play a crucial role in transduc-
tion of TCR-mediated signaling. Experiments were per-
formed to investigate whether the ZAP-70 kinase activa-
tion is normally induced in H1R2/2 mouse T cells (Fig. 7).
c-kit–positive cell-depleted spleen cells from wild-type or
H1R2/2 mice were stimulated with anti-CD3e antibodies
in RPMI 1640 medium with dialyzed FCS. Whole cell ly-
sates from anti-CD3e–stimulated spleen cells were immu-
noprecipitated with anti–ZAP-70 and blotted with an-
tiphosphotyrosine antibodies. In wild-type mouse T cells,
tyrosine phosphorylation of ZAP-70 kinase was induced
after stimulation with anti-CD3e (Fig. 7, left), and the ty-
rosine phosphorylation was strongly enhanced in the pres-
ence of histamine (1025 M) (Fig. 7, middle). On the other
hand, phosphorylation of ZAP-70 in spleen T cells was
greatly reduced in the H1R2/2 mouse (Fig. 7, right).
These results suggest a crucial role of signaling from the
histamine H1Rs in TCR-mediated protein tyrosine phos-
phorylation in the proximal signaling pathways.
In Vitro Cytokine Production by Spleen Cells from H1R2/2
Mice. Cytokine production in response to OVA or anti-
CD3e cross-linking was assessed by using spleen cells from
Figure 6. Level of Ig subclass in H1R2/2 mice before and after immunization with the T cell–dependent antigen, OVA. (A) Levels of serum Ig sub-
class in unimmunized mice. Serum Ig levels in 8–10-wk-old H1R2/2 mice (2/2) and their wild-type littermates were determined by isotype-specific
ELISA. d, control (1/1); s, mutant (2/2) mice. Shown are the results from five mice of each group. (B) Levels of anti-OVA antibody titers of each
Ig isotype after secondary immunization. Serum samples were collected 2 wk after the second immunization. Titers of OVA-specific antibodies were de-
termined by isotype-specific ELISA. Serum antibody levels are expressed as OD450. Shown are the results from five mice of each group. Horizontal lines
indicate mean.679 Banu and Watanabe
the wild-type and H1R2/2 mice that had been immunized
with OVA. Cells were cultured in presence of various con-
centration of OVA (5–50 mg/ml) or in anti-CD3e–coated
plates for 72 h. The culture supernatants were collected to
determine the amount of IL-2, IL-4, and IFN-g. The re-
sults are shown in Table I. Compared with the level of cy-
tokines produced by wild-type mouse spleen cells upon
stimulation with OVA antigen or anti-CD3e cross-linking,
the amounts of IL-2 and IFN-g produced by spleen cells
from H1R2/2 mice was significantly reduced, whereas the
IL-4 level was not decreased, but rather was enhanced.
These results suggest that the production of Th1-derived
cytokines, which is triggered by TCR signals, might be
more dependent on the signal(s) from histamine H1Rs than
Th2-type cytokine production, and that Th2 activation
might be negatively regulated by the signal(s) from hista-
mine H1Rs.
Discussion
In this study, we describe the effect of histamine H1R
signals on antigen receptor–mediated T and B cell signal-
ing. Histamine caused a dose-dependent increase in the
proliferation of splenic T and B cells induced by cross-link-
ing of antigen receptors with anti-CD3 and anti-IgM, re-
spectively. The enhanced response was only observed if the
population of c-kit–positive cells, which includes mast
cells, was depleted before culture, and if the FCS was dia-
lyzed before use as a media supplement. In vitro T cell pro-
liferative responses triggered by anti-CD3e antibody or an-
tigen stimulation with OVA were markedly decreased in
mice lacking H1R. Anti-IgM–stimulated proliferation of B
cells was also impaired in H1R2/2 mice. In contrast, the
responses to IL-2, LPS, IL-4, CD40L, and CD40L plus IL-4
were unaffected by the absence of H1R. These results
strongly suggest a significant contribution of signal(s) from
the histamine H1R to the antigen receptor–mediated sig-
naling pathways that induce proliferative responses in T
and B cells.
TCR signaling has been reported to act on Gaq, and re-
sults in its physical association with CD3e (17). Activation
of protein tyrosine kinases could result in Gaq and Gaq/11
phosphorylation, thus augmenting GPCR-mediated Gaq/11
signaling (12, 13). Therefore, Gaq/11 could mediate both
tyrosine phosphorylation of CD3 and IP3 generation upon
TCR engagement. The cross-linking also induced Pyk2
activation in T cells, which may potentially serve as a con-
vergence point for TCR and GPCR signaling (18–20). It is
noteworthy that the Gaq protein appears to associate with
the histamine H1R as a signal transducer (26, 27, 41). Gq-
mediated signaling also triggers the translocation of the
transcription factor nuclear factor (NF)-AT to the nucleus,
which is involved in IL-2 gene activation, providing an-
other mechanism by which TCR and GPCR-linked sig-
naling pathways may communicate with each other (21). It
has been reported that the cells derived from the human
Jurkat T cell line, which carried a function-deficient mu-
tant of Gaq/11, displayed diminished tyrosine phosphory-
lation of TCR/CD3z and e chains, as well as ZAP-70,
upon anti-CD3 antibody triggering (17). Reduced tyrosine
phosphorylation of ZAP-70 was also observed in H1R2/2
spleen T cells after cross-linking of TCR by anti-CD3 an-
tibody (Fig. 7). Moreover, addition of histamine enhanced
tyrosine phosphorylation of ZAP-70 in anti-CD3–stimu-
lated T cells of wild-type mice. Present data prove the
speculation that signals from GPCR may regulate the
TCR-mediated ZAP-70 activated tyrosine phosphoryla-
tion. Thus, the low T cell proliferative responses observed
in the H1R2/2 T cells may suggest a possible interaction
between TCR and GPCR signaling triggered by H1R. In-
terestingly, not only proliferative responses, but also pro-
duction of cytokines, such as IL-2 and IFN-g, were im-
paired in H1R2/2 spleen T cells as compared with T cells
of the normal littermates upon cross-linking of TCR with
anti-CD3 or antigen (OVA) in vitro (Table I). On the
other hand, in the case of IL-4 production was not re-
Figure 7. Tyrosine phosphorylation of ZAP-70 kinase after the cross-
linking of TCR with anti-CD3e in the absence or presence of histamine.
c-kit–positive cell-depleted splenic T cells from wild-type (H1R1/1; left
and center) or H1R2/2 (right) mice were incubated with goat anti–
mouse CD3e antibody (10 mg/ml) with or without histamine for 0–10
min. Cell lysates were immunoprecipitated with affinity-purified goat
anti–mouse ZAP-70 antibody. Immunoprecipitates were fractionated on
10% SDS-polyacrylamide gels. The proteins on the gels were transferred
onto nitrocellulose membrane filter and blotted with an HRP-labeled an-
tiphosphotyrosine mAb, PY-20. The blots were visualized with enhanced
chemiluminescence reagents. The position of the band representing
ZAP-70 phosphorylation is indicated by an arrow at 70 kD.
Table I. Cytokine Production from Spleen Cells of Wild-type
and H1R2/2 Mice upon Stimulation with Antigen (OVA) or
Anti-CD3e Antibody
Stimulator
(cytokine
produced)
OVA (40 mg/ml) Anti-CD3e (10 mg/ml)
IL-2 IFN-g IL-4 IL-2 IFN-g IL-4
pg/ml pg/ml
H1R1/1 280 6 59  6 2 10 6 2 620 6 20 280 6 5 25 6 5
H1R2/2 22 6 55  6 1 20 6 2 35 6 5 10 6 2 100 6 11
Spleen cells were cultured in vitro with OVA (40 mg/ml) or goat anti–
mouse CD3e antibody (40 mg/ml) for 3 d. The culture supernatants
were used for detection of IL-2, IL-4, and IFN-g by quantitative
ELISA.680 Effect of Histamine on Immune Responses
duced, but rather was enhanced. These results suggested
that H1R-mediated signal(s) may play a crucial role in anti-
gen-receptor signaling mainly in Th1-type T cells, and it
might be possible that signal(s) from H1R may function as
a feedback regulator for activation of Th2-type T cells.
It has been reported that a Gaq activates Btk (23), and
the Gbg subunit binds and activates Btk (24, 25), which
implicates Gaq in B and mast cell function. Thus, engage-
ment of either the BCR or a Gq-linked GPCR could acti-
vate Btk in B cells. The xid (CBA/N) mice carry a point
mutation in the pleckstrin homology domain of Btk. These
mice exhibit reduced numbers of mature B cells, reduced
serum levels of IgM and IgG3, and low proliferative re-
sponses to anti-IgM and LPS stimulation in vitro (43), and
also lack CD51 B-1 cells in the peritoneal cavity. The
H1R2/2 mice showed normal differentiation pattern of B
and T cells, and the numbers of mature B and T cells were
within normal range. However, the response to anti-IgM
cross-linking was reduced (Fig. 2) and serum levels of IgG3
and IgM class antibodies were low (Fig. 6). These data sug-
gest that signal(s) from the G protein coupled to the hista-
mine H1Rs may contribute through Btk to the activation
of B cells induced by antigen receptor signaling, but not
during B cell maturation or in the case of a mitogenic re-
sponse. Interestingly, the proportion of CD51 B-1 cells
was found to be decreased in the peritoneal cavity of the
H1R2/2 mice to half of that of normal littermates, suggest-
ing the impaired activation of Btk in B1 cells in the H1R
gene knockout mice. All these findings related to GPCR-
mediated signaling lead us to postulate that ligand–GPCR
binding triggers the tyrosine phosphorylation of members
of the antigen receptor complex, thereby modifying anti-
gen receptor signaling. Furthermore, activation of the his-
tamine H1R may produce functional signals in cells via the
Gq/11 family of G proteins and communicate with antigen
receptor-mediated signaling, which results in the augmen-
tation of proliferative responses induced by cross-linking of
the TCR and BCR.
Proliferative responses of H1R2/2 T and B cells in re-
sponse to stimulation with anti-CD3 or anti-IgM antibod-
ies were lower than those of control littermates in the ab-
sence of histamine (Fig. 1 versus Fig. 2). This may suggest
the existence of an endogenous or exogenous H1R li-
gand(s) other than histamine, which may also affect antigen
receptor–mediated activation of the lymphocytes, and thus
the lack of H1R results in more pronounced effects. One
of the possibilities is that a signal(s) from histamine H2Rs
may play a role in H1R2/2 mice since there was a report
that the signal(s) from H2R appeared to suppress the pro-
duction of certain types of cytokines, such as IL-10 and
IL-12, from Th cells (44). Therefore, it is possible to specu-
late that the H1R-mediated signal(s) may be augmented in
H1R2/2 T cells. To discover the role of histamine H2R in
immune response in H1R2/2 mice, the spleen T and B cells
of H1R2/2 mice were stimulated with anti-CD3e and anti
IgM, respectively, in the presence of varying concentrations
of an H2 antagonist, famotidine, (1024 M to 1027 M). The
addition of Famotidine revealed a 20–40% reduction of
proliferative responses of both T and B cells (data not
shown). These data implicate the part of dependency of the
remaining proliferative responses of H1R2/2 T and B cells
on the H2R-mediated signaling, but low proliferative re-
sponses of H1R2/2 T and B cells was not due to the sup-
pression through the H2R-mediated signaling. Alterna-
tively, H1R knockout mice may carry an unknown
genetic polymorphism that causes a low response to anti-
gen receptor–mediated signaling, since the background of
H1R2/2 mice and their control littermates is not homoge-
nous, although they have been backcrossed to C57BL/6
for more than five generations.
Mast cells were once considered mere effector cells for
IgE-mediated hypersensitivity that released pharmacologi-
cally active mediators, including histamine. However, in
recent years, with the realization that mast cells also secrete
cytokines, the involvement of this cell type in regulating
the immune response has become appreciated (45, 46).
Our studies indicate that the mast cell product histamine
may play an even more direct role in acquired immunity
than was previously suspected.
Although the precise molecular mechanism remains ob-
scure, further detailed investigation of the interaction of the
H1R with the G proteins should reveal the importance of
the cross-talk between GPCR-mediated and antigen re-
ceptor–mediated signaling pathways.
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